220 likes | 238 Views
The global cardiac biomarkers market was worth US$ 7.5 Billion in 2019. Looking forward, IMARC Group expects the market to exhibit moderate growth during 2020-2025.<br><br>To learn more about this market, visit us at: https://www.imarcgroup.com/cardiac-biomarkers-market<br><br>We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.<br><br>Changing lifestyles, hectic schedules and shifting dietary patterns have resulted in the frequent occurrence of chronic diseases such as diabetes and CVDs. This, along with growing awareness among the majority of the population regarding the importance of early diagnosis of these chronic diseases, is driving the demand for cardiac biomarkers. The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players. <br><br>For more information, request for a free sample report here: https://www.imarcgroup.com/cardiac-biomarkers-market/requestsample<br><br>Contact Us:<br><br>IMARC Group<br>30 N Gould St, Ste R<br>Sheridan, WY (Wyoming) 82801 USA<br>Email: Sales@imarcgroup.com<br>Tel No:(D) 91 120 433 0800<br>Americas:- 1 631 791 1145 | Africa and Europe :- 44-702-409-7331 | Asia: 91-120-433-0800, 91-120-433-0800
E N D
Global Cardiac Biomarkers Market Research Report and Forecast 2020 - 2025 www.imarcgroup.com Sales@imarcgroup.com +1-631-791-1145
About IMARC WHO WE ARE? • We are a leading market research firm with expertise in market intelligence and business research • We deliver high quality, well- knitted, meaningful studies • We excel at understanding and synergizing with the business priorities of our partners and delivering tailored solutions WHAT DO WE DO? • Market research and business insights • Competitive intelligence and benchmarking • Strategy consulting • Consumer surveys and feedback analysis • Social and rural research • Market entry strategy • Syndicated Reports WHAT DO WE COVER? • Food And beverages • Dairy and dairy products • Agriculture and farming • Chemicals and materials • FMCG • Paper and packaging • Healthcare • Machinery, electronics and semiconductors WHO DO WE SERVE? • Collaborating with fortune 500 companies and SMEs • Serving all major clients from different industry which include Chemical & Materials, Food & Beverages, Packaging, Healthcare, Automotive, Heavy Industries, Retail, etc.
What We Do Competitive Intelligence and Benchmarking At IMARC, we help customers determine a competitor’s brand image and perception in the marketplace as compared to other key players. Cost Modeling and Cost Forecasting A good cost model supports organizations during negotiations to build strong relationships with suppliers. Cost modelling and price forecasting services from IMARC ensure clients make informed decisions. Market Research & Business Insights To develop deep customer understanding, we employ a range of quantitative and qualitative marketing research approaches along with big data techniques that are both innovative and pragmatic Country Entry Strategy IMARC team drafts and implement an optimum country entry strategy for expanding business in the country. Our team of consultants deeply evaluates and strategize the market opportunities for our clients and accentuate the business in congruence with Government regulations, exports and imports scenario, demand supply gap analysis and many more. Consumer Survey & Feedback Reports Consumer profiling, survey with end consumers, collection of their feedback and deep analysis. Based on the analysis, strategic decisions to enter in a new region, launch of new product, improvising the existing services Consumer Survey & Feedback Reports Competitive Intelligence and Benchmarking Cost Modeling and Cost Forecasting Market Research & Business Insights Country Entry Strategy
REPORT OBJECTIVES & Highlight
Report Description As per the latest report by IMARC Group, titled “Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the global cardiac biomarkers market size reached US$ 6.9 Billion in 2018. Cardiac biomarkers refer to endogenous substances including enzymes, hormones and proteins, which are released into the bloodstream when the heart muscles are damaged, or the organ is stressed. Also known as cardiac enzymes, these substances include myoglobin, troponin, creatine kinase and ischemia-modified albumin. The measurement of these markers aids in diagnosing conditions associated with insufficient blood flow to the heart. They evaluate the heart’s function and assist in the early diagnosis of certain diseases. They are also used in the risk stratification of patients with chest pain and cardiovascular diseases (CVDs), such as suspected acute coronary syndrome (ACS) or myocardial infarction (MI). Physicians now widely prefer cardiac biomarker measurements over cardiac imaging diagnosis as these procedures are relatively simpler, cost-effective, and offer highly accurate results. Request for a free sample copy of this report: https://www.imarcgroup.com/control-valves-market/requestsample Market Trends: Changing lifestyles, hectic schedules and shifting dietary patterns have resulted in the frequent occurrence of chronic diseases such as diabetes and CVDs. This, along with growing awareness among the majority of the population regarding the importance of early diagnosis of these chronic diseases, is driving the demand for cardiac biomarkers. Also, quicker results and easy availability of point of care (POC) cardiac testing kits are further providing a thrust to the market growth. Furthermore, manufacturers are continually engaging in research and development (R&D) activities to develop technologically advanced product variants such as multi-assay biomarkers. Other factors creating a positive outlook for the market include rapid urbanization, rising disposable income, and favorable government initiative for making quality healthcare services accessible to all.
Report Description On account of the aforementioned factors, the market is anticipated to reach a value of US$ 11.6 Billion by 2024, growing at a CAGR of around 9% during 2019-2024. Cardiac Biomarkers Market : Segmentation and Analysis of Top Key players Historical, Current and Future Market Trends • Market Breakup by Type 1 Troponins (T and I) 2 Myocardial Muscle Creatine Kinase (CK-MB) 3 Myoglobin 4 Brain Natriuretic Peptide (BNPs) or NT-proBNP 5 Ischemia Modified Albumin (IMA) 6 Others • Market Breakup by Location of Testing 1 Laboratory Testing 2 Point of Care Testing • Market Breakup by Application 1 Myocardial Infarction 2 Congestive Heart Failure
Report Description • 3 Acute Coronary Syndrome 4 Atherosclerosis 5 Others Market Breakup by Region 1 North America 2 Asia Pacific 3 Europe 4 Middle East and Africa 5 Latin America • Competitive Landscape 1 Market Structure 2 Key Players 3 Profiles of Key Players Explore full report with table of contents: https://www.imarcgroup.com/cardiac-biomarkers-market
Report Description Key Questions Answered in This Report: •How has the global cardiac biomarkers market performed so far and how will it perform in the coming years? •What are the key regional markets in the global cardiac biomarkers industry? •What is the breakup of the global cardiac biomarkers market on the basis of type? •What is the breakup of the global cardiac biomarkers market on the basis of location of testing? •What is the breakup of the global cardiac biomarkers market on the basis of application? •What are the various stages in the value chain of the global cardiac biomarkers market? •What are the key driving factors and challenges in the global cardiac biomarkers market? •What is the structure of the global cardiac biomarkers market and who are the key players? •What is the degree of competition in the global cardiac biomarkers market?
Table of Contents 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Cardiac Biomarkers Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Type 5.4 Market Breakup by Location of Testing 5.5 Market Breakup by Application 5.6 Market Breakup by Region 5.7 Market Forecast
Table of Contents 6 Market Breakup by Type 6.1 Troponins (T and I) 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Myocardial Muscle Creatine Kinase (CK-MB) 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Myoglobin 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Ischemia Modified Albumin (IMA) 6.5.1 Market Trends 6.5.2 Market Forecast 6.6 Others 6.6.1 Market Trends 6.6.2 Market Forecast 7 Market Breakup by Location of Testing 7.1 Laboratory Testing 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Point of Care Testing 7.2.1 Market Trends
Table of Contents 7.2.2 Market Forecast 8 Market Breakup by Application 8.1 Myocardial Infarction 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Congestive Heart Failure 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Acute Coronary Syndrome 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Atherosclerosis 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Others 8.5.1 Market Trends 8.5.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Asia Pacific 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Europe 9.3.1 Market Trends
Table of Contents 9.3.2 Market Forecast 9.4 Middle East and Africa 9.4.1 Market Trends 9.4.2 Market Forecast 9.5 Latin America 9.5.1 Market Trends 9.5.2 Market Forecast 10 Global Cardiac Biomarkers Industry: SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11 Global Cardiac Biomarkers Industry: Value Chain Analysis 12 Global Cardiac Biomarkers Industry: Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Global Cardiac Biomarkers Industry: Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players
Table of Contents 14.3.1 Abbott Laboratories 14.3.2 Alere Inc. 14.3.3 Beckman Coulter 14.3.4 Becton, Dickinson And Co. 14.3.5 Biomerieux 14.3.6 Bio-Rad Laboratories 14.3.7 Randox Laboratories 14.3.8 Roche Diagnostics Corporation 14.3.9 Siemens Healthcare 14.3.10 Thermo Fisher Scientific Browse Related Report High performance liquid chromatography market: https://www.imarcgroup.com/high-performance-liquid-chromatography- market Europe fmd vaccine market: https://www.imarcgroup.com/europe-fmd-vaccine-market
Report FAQs Team Profile Team Profile
Team Profile Growing team of 150+ employees with deep market knowledge Engineers and Post Graduates Account for 75% of our Team Post Graduates 30% Over 1000 Independent Consultants from different sectors Engineers 45% Talents from some of the top universities modelling specialists with unmatched expertise in quantitative research Individuals with experience in specific industries and having sound knowledge of targeted functional areas Non Engineering Graduates 15% Commercial and non-commercial relationships with some of the top research institutes Others 10%
Report FAQs Words From Client
Words From Client “We have been working with IMARC Group for over two years now. I must say that the word impossible doesn’t seems to appear in their dictionary,. These guys can provide data for any market in any country. I have been given them challenging assignments to work upon and have been quite impressed with their approach and results.” Procurement Technology Manager – Global FMCG Giant -Global “IMARC Group has great domain expertise and knowledge base provided all the inputs necessary for us to define the path forward and launch our diagnostic successfully in the market where other players were always afraid before investing.” -Vice President Marketing – European Diagnostic Company “We were really impressed with their research findings on the South India dairy market. The innovative idea suggested by them have given us altogether different aspect to look at the problem. We started with them on small project but now thinking on doing more strategic project with them.” -National Manager (Marketing) – Indian Diary Giant “IMARC Group helped us with the outsourcing of a major part of clinical trials to India. In the beginning we were skeptic of this idea. But the success achieved from this strategy is driving us to outsource other verticals of our business to low cost destinations” - Member of Board of Managing Director – Global Pharmaceutical Giant “Working with IMARC Group has been a great experience. They were able to provide us with a comprehensive business report on the India wastewater treatment market. The finding from the reports are played a major role in our business strategies and future decision making” -Senior Vice President – Major Indian Effluent Treatment Company
Report FAQs Report FAQs
Report FAQs 01 02 03 Do you provide market share information for a specific country/segment? Yes, we provide market share information and insights considering the scope. This service is provided as a part of customization requirements. My research requirement is very specific; can I customized the report? Yes, we provide customization of reports based on your requirements. It will be charged based on the scope of customization. Client have free access to pre-sales analyst briefs to discuss requirement and recommendations. How do you arrive at the market numbers? Our research methodology is a three cyclic process. It starts from information procurement from our inhouse database, primary research and secondary sources. The second step is data collection and analysis. The third step is data validation from industry experts, key players and other stakeholders. 04 05 I have a pre-defined budget. Can I buy chapters/sections of the report? We generally do not promote the sale of separate or individual segments from within a study, as it might fail to relay the actual meaning of the study or provide a holistic picture of the market. However, in special cases, select chapters are provided based on the client requirement. Do you offer post sales support? Yes, we offer post purchase analyst support for 4-6 weeks to our client in case they have any query within the scope of study.
Report FAQs 06 07 Who are your client? We have engaged 550+ clients across the globe. More than half of our client are re-engage us for additional reports and services How will I receive the report? The report in a PDF and Excel format will be sent to you electronically at your registered email address. Moreover, PPT and Word formats are also delivered to clients, on special requests. 08 09 How often does IMARC update studies? Research studies or reports are updated once in 6 months or a year depending on the traction & need. Please contact our sales team to inquire about a report update status. Will I have to pay for the post-sale customization needs? We offer our clients with a free 10% customization on the syndicated report. In case you have not availed this service as a pre-sale facility, we request you to share the requirements with our sales team. The research team post a feasibility will share the purview of the post-sale customization along with the price (if applicable) and the timeline.